Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
CONCLUSIONS: In our study population there was no statistically significant difference regarding survival and estimated recurrence rates between both arms of this study. We found a trend toward less dysphagia at 6months (however not significant after longitudinal analysis) and found a significant reduction of any salivary gland toxicity at 6 and 18months in the 40Gy arm.
PMID: 27528118 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Nevens D, Duprez F, Daisne JF, Dok R, Belmans A, Voordeckers M, Van den Weyngaert D, De Neve W, Nuyts S Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Head and Neck Cancer | HNSCC | Intensity-Modulated Radiation Therapy | Radiology | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study | Toxicology